April 2011 | MD Anderson Cancer Center Skip to Content
Top

BY Scott Merville

After years of failure in the treatment of advanced melanoma, two new drugs have emerged that help patients with one of the most deadly and difficult-to-treat cancers.

The experimental drug PLX4032 targets a specific genetic mutation found in the tumors of about half of all patients. Ipilimumab, an antibody that stimulates an immune system attack on melanoma, recently was approved by the U.S. Food and Drug Administration for treatment...

BY Scott Merville

Like the plastic tips on shoelaces, telomeres sit at the end of chromosomes, protecting them from unraveling telomeres are protective, preventing...